Laura Hart

Laura Hart, MD, FACOG is an Associate Professor in the Department of Clinical Obstetrics, Gynecology & Reproductive Science at the Lewis Katz School of Medicine at Temple University. She serves as Medical Director of the Temple/Wedge Opioid Treatment Program and Co-Director of the Cardio-Obstetrics Program, reflecting her leadership in high-risk maternal care.

Her education includes an MD from St. George’s University School of Medicine, a residency in Obstetrics & Gynecology at Drexel University College of Medicine, and a fellowship in Maternal-Fetal Medicine at The University of Texas Health Science Center at Houston.

Dr. Hart's research and clinical interests focus on medical complications of pregnancy, including hypertension, preeclampsia, critical care obstetrics, and opioid use disorder. Her work bridges clinical practice and academic inquiry, with a strong emphasis on improving outcomes for high-risk pregnancies. She has contributed to evidence-based guidelines and conducted research on fetal monitoring, delivery timing, and cardiovascular complications in pregnancy.

Her publications span topics such as respiratory diseases in pregnancy, seizures in pregnancy, placenta previa management, and transgenerational epigenetic effects. The research demonstrates a consistent focus on maternal safety, fetal well-being, and evidence-based decision-making in complex obstetrical scenarios.

Notable awards include:

• National Award for Excellence in Teaching, Council on Resident Education in Obstetrics and Gynecology (2016)
• Young Investigator Award, Central Association of Obstetricians and Gynecologists
• Multiple teaching honors including the Golden Apple Award and Arnold P. Gold Foundation Award for Humanism
• Early academic distinctions from St. George’s University and Drexel University

Dr. Hart is actively involved in resident education and clinical mentorship, though specific advisees are not listed. She has no known grants mentioned, but her leadership roles suggest involvement in programmatic funding and clinical initiatives. Her work in LGBTQ-inclusive care, evidenced by Safe Zone training, underscores her commitment to patient-centered, equitable healthcare delivery.

She practices at the Temple Perinatal Diagnosis Center (Fetal Center) in Philadelphia and leads specialized programs addressing opioid use and cardiovascular risks in pregnancy, indicating active clinical and administrative engagement.